Navigation Links
WuXi PharmaTech Announces Third-Quarter 2013 Results
Date:11/12/2013

guidance and our goal of building an open-access technology platform. Although we believe that our predictions are reasonable, future events are inherently uncertain, and our forward-looking statements may turn out to be incorrect. Our forward-looking statements are subject to risks relating to, among other things, our ability to control our costs and sustain revenue growth, to realize the anticipated benefits of our investments, to protect our clients' intellectual property, and to compete effectively. Additional information about these and other relevant risks can be found in our Annual Report on Form 20-F for the year ended December 31, 2012. The forward-looking statements in this press release speak only as of the date on which they are made, and we assume no obligation to update any forward-looking statements except as required by law.

Use of Non-GAAP and Pro-Forma Financial Measures  We have provided the third-quarter and nine-months 2012 and 2013 gross profit, gross margin, operating income, operating margin, net income, net margin, and earnings per ADS on a non-GAAP basis, which excludes share-based compensation expenses and the amortization and deferred tax impact of acquired intangible assets. We believe both management and investors benefit from referring to these non-GAAP financial measures in assessing our financial performance and liquidity and when planning and forecasting future periods. These non-GAAP operating measures are useful for understanding and assessing underlying business performance and operating trends. We expect to continue to provide net income and earnings per ADS on a non-GAAP basis using a consistent method on a quarterly basis. You should not view non-GAAP results on a stand-alone basis or as a substitute for results under GAAP, or as being comparable to results reported or forecasted by other companies, and you should refer to the reconciliation of GAAP measures to non-GAAP measures for the indicated periods
'/>"/>

SOURCE WuXi PharmaTech
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. WuXi PharmaTech Announces Licensing Agreement for Patient-Derived Xenograft Models with Mayo Clinics Center for Individualized Medicine
2. Zacks.com featured expert Kevin Matras highlights: Core Laboratories NV, Invesco Ltd., Medtronic, Inc., Willbros Group Inc. and WuXi PharmaTech Inc.
3. WuXi PharmaTech Schedules First-Quarter 2013 Earnings Release
4. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
5. WuXi PharmaTech Receives Letter from AAALAC Commending Animal Care at Suzhou Toxicology Facility as "Exemplary"
6. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
7. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
8. WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
9. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
10. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
11. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015  Shares of Celladon Corp. (NASDAQ: CLDN ... the announcement of poor drug trial results of the phase ... agent, MYDICAR.  The selloff may be warranted or it ... bargain basement prices. An analyst report update ... pipeline, financial review, analyst summary, valuation, and recommendation can ...
(Date:4/28/2015)... Israel , April 28, 2015 ... in its sixth funding cycle for U.S.- Israel ... and Energy Efficiency. To be considered, a project ... between a company and a university/research institution (one from the ... proposal should have significant commercial potential and the project outcome ...
(Date:4/27/2015)... Techpool Bio-Pharma Co has experienced tremendous changes in ... chief executive officer, transforming from a traditional private Chinese company ... took office in 2011, he was the senior executive ... and Eisai, with more than 20 years successful management experience ... Asia-Pacific region. "I chose Techpool ...
Breaking Medicine Technology:Examining what's Left after MYDICAR Drug Trial Ends In Failure; Celladon Corp. Analyst Report Issued by BrokerBank Securities, Inc. 2Opportunities for Funding U.S.-Israel Cooperation for Renewable Energy and Efficiency 2Techpool Transforms Into International Player 2Techpool Transforms Into International Player 3
... 9, 2011 NeurogesX, Inc. (Nasdaq: NGSX ... novel pain management therapies, today announced it will hold ... p.m. ET (1:30 p.m. PT) to provide an update ... patch for the management of neuropathic pain associated with ...
... Misonix, Inc. (Nasdaq: MSON ), ... markets innovative, therapeutic, ultrasonic products worldwide for wound ... surgical and medical applications, today reported financial results ... ending December 31, 2010.  Michael A. McManus Jr., ...
Cached Medicine Technology:NeurogesX to Provide Qutenza® Launch Update 2NeurogesX to Provide Qutenza® Launch Update 3NeurogesX to Provide Qutenza® Launch Update 4Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 2Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 3Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 4Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 5Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 6
(Date:4/28/2015)... New and more complex medicines ... manufacturers, payers, pharmacists and patients. Now Specialty Pharmacy ... partnering with the National Association of Specialty Pharmacy ... to this developing field to better equip pharmacy ... , “This partnership creates a powerful platform for ...
(Date:4/28/2015)... 28, 2015 Celebrating women has become a ... be the third year that all things mom and female ... Hands On is offering some great specials Special ... of the year could there be to focus on woman," ... pampering and this is a terrific time for it. And ...
(Date:4/28/2015)... 28, 2015 SeniorCare.com has published the ... the reality problem Americans have regarding aging and long-term ... long-term care services as they age, 63% of Americans ... , In the report, Carol Marak of SeniorCare.com interviewed ... American Health Care Association and The Scan Foundation. The ...
(Date:4/28/2015)... Once considered an unproven alternative to HID lighting, the ... storm with perfectly tailored light spectrums in an ideal, low ... than half of every SuperCloset and SuperRoom sold are now ... is gone and LED Grow Lights are here to stay. ... their first hand experience using the new LED Grow lights ...
(Date:4/28/2015)... The west coast, south, east coast, ... areas that healthcare professionals searched for jobs through the ... of March 2015. Data was released by the ... jobs , physical therapy jobs , and other ... health fields. , States with the most ...
Breaking Medicine News(10 mins):Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 4Health News:Commack Massage Therapy and Wellness Day Spa Dedicates Time To Celebrate Women 2Health News:SeniorCare.com Report: America Has a Major Misconception on Aging 2Health News:SuperCloset Reports Surge in KIND LED Grow Light Sales, Saving Indoor Growing Enthusiasts up to 40% on their Power Usage. 2Health News:Hot States for Medical Careers: Healthcare Staffing Agency Aureus Medical Releases Online Search Results 2
... genetic factors and drug abuse saying that genetic tendencies play ... ,Dr. Kenneth S. Kendler, who has led the ... the importance of genetic factors in a culture/country (Norway) with ... that in such countries, social rather than genetics factors should ...
... When the body's arteries, veins and capillaries become diseased, ... the possibility of stroke and heart attack.// Dennis Gable, ... Baylor Regional Medical Center at Plano, provides information about ... ,Varicose veins: ,Varicose veins are large, twisted, swollen ...
... person dying of coronary heart disease can be predicted by ... venules in the eyes. ,Arterioles and venules are ... reflects the general state of the smaller blood vessels in ... of the study, 78 women (just over 4%) and 114 ...
... be a wake up call to get the duvets washed and ... their duvets even in six months, and these could// be the ... ,A survey conducted in many households revealed that two ... months. The dust mites and filth are potential health hazards ...
... have said one therapeutic dose of radiation resulted in mice ... ,Research in US have indicated, in a study ... Physiology that mice that has received a single therapeutic dose ... of radiation received by human cancer patients lost as much ...
... NHS has launched National Transplant Week to raise awareness of ... take place and the number of people// awaiting transplants. ... population in Britain has joined the Organ Donor Register. In ... on transplant lists, only 2,200 actually operations took place. ...
Cached Medicine News:Health News:Vascular Disease 101: Discovering and Treating Common Diseases of the Veins 2Health News:National Transplant Week to Raise Need for Organ Donation 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: